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ABSTRACT
Reliable data concerning the incidence and phenotypic and genotypic characteristics of the Neisseria
gonorrhoeae population in many eastern European countries are lacking. Clinically significant N. gonor-
rhoeae isolates (n = 76) from 76 consecutive patients in Arkhangelsk, Russia were characterised by
antimicrobial susceptibility testing, serovar determination, porB gene sequencing and N. gonorrhoeae
multi-antigen sequence typing (NG-MAST). The isolates were assigned to 12 different serovars, displayed
35 divergent porB sequences, and belonged to 40 different sequence types (STs). All the serovars, but only
seven of the STs, had been identified previously in other countries. Twelve ST clusters of between two and
14 isolates were identified, which indicated that many multiple transmission networks exist in
Arkhangelsk. The high number of unique STs (n = 28) may be a consequence of sub-optimal diagnostic
procedures, ineffective partner tracing, local emergence of new STs, import of strains via sexual tourists, or
foreign travel. The N. gonorrhoeae population circulating in Arkhangelsk was highly diverse and differed
from the N. gonorrhoeae populations disseminated in some western European countries. Thorough
knowledge concerning the incidence of gonorrhoea, antibiotic susceptibility and other phenotypic and
genotypic characteristics of the N. gonorrhoeae strains circulating in eastern Europe is crucial.
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INTRODUCTION
Since the mid-1990s or late 1990s, the incidence
of gonorrhoea has increased in several western
European countries [1] (http://www.epinorth.
org, http://data.euro.who.int/cisid). In contrast,
the estimated incidence of gonorrhoea in several
eastern European countries, e.g., Russia, Belarus,
Lithuania, Latvia and Estonia, has declined [2–4]
(http://www.epinorth.org; http://data.euro.
who.int/cisid). However, reliable data concerning
the incidence of gonorrhoea in many of these
countries are lacking because of (e.g.) incomplete
case reporting and ⁄ or sub-optimal diagnosis
[2–5]. Furthermore, comprehensive knowledge
regarding the antimicrobial susceptibility and
serological variants (serovars), as well as the
molecular epidemiological characteristics, of the
Neisseria gonorrhoeae populations that are trans-
mitted in these countries is absent. These facts are
disturbing, since prevention of gonorrhoea is
based on the availability of effective diagnostic
procedures, antimicrobial treatment and tradi-
tional epidemiological approaches (e.g., partner
tracing), as well as regional, national and inter-
national surveillance of the epidemiological
characteristics and increasing antimicrobial resist-
ance of N. gonorrhoeae. Consequently, precise
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phenotypic and genotypic characterisation of
N. gonorrhoeae isolates is crucial for gonorrhoea
case management and for the development of
improved control measures and interventions.
In 2004, the incidence of gonorrhoea in the
Arkhangelsk region, north-west Russia (popula-
tion c. 1.3 million), was estimated to be
135.9 cases ⁄ 100 000 inhabitants (http://www.
epinorth.org). However, diagnostic procedures
for gonorrhoea are rarely performed in Arkhan-
gelsk in full accordance with international recom-
mendations [6–8], and antimicrobial susceptibility
testing of N. gonorrhoeae isolates is performed
rarely [5]; other phenotypic and genotypic tests
are not performed because of their expense. The
antimicrobial susceptibilities of N. gonorrhoeae
isolates from Arkhangelsk were investigated for
the first time in a recent study [5]. The aims of the
present study were to determine the phenotypic
and genotypic characteristics of clinical N. gonor-
rhoeae isolates cultured in Arkhangelsk, and to
compare them with those of the N. gonorrhoeae
populations disseminated in western European
countries.
MATERIALS AND METHODS
N. gonorrhoeae isolates were obtained in June–November 2004
from 76 mainly consecutive patients (one isolate ⁄patient) [5],
preserved at )70C and subsequently grown as described
previously [9]. All isolates were confirmed as N. gonorrhoeae
and tested for b-lactamase production and susceptibility to
penicillin G, ampicillin, cefixime, ceftriaxone, erythromycin,
azithromycin, kanamycin, spectinomycin, ciprofloxacin and
tetracycline as part of a previous study [5]. Serovar deter-
mination was performed as described previously [10].
Sequencing of the entire porB gene and N. gonorrhoeae
multi-antigen sequence typing (NG-MAST), together with
subsequent sequence and phylogenetic analyses, were also
performed as described previously [11,12].
RESULTS
Phenotypic and genotypic characterisation of
isolates
The results of the serovar determination and
genotypic characterisation of the isolates are sum-
marised in Figs 1 and 2. Twenty (26%) isolates
belonged to serogroup PorB1a (WI), while the
remaining 56 isolates were assigned to serogroup
PorB1b (WII ⁄ III). All the isolates were serotype-
able and were distributed among 12 serovars.
Serovars IA-6 (n = 17), IB-1 (n = 23) and IB-3
(n = 12) predominated, while four serovars were
represented by single isolates (Fig. 1).
The isolates displayed three different porB1a
gene sequences and 32 divergent porB1b
sequences. Of these 35 different porB sequences,
five (14%) were identified in isolates that had
divergent serovars despite an identical porB
sequence (Fig. 1). The isolates showed 30 and 25
divergent partial NG-MAST porB and tbpB alleles,
respectively, which resulted in the assignment of
40 different sequence types (STs). ST758 (n = 14),
ST387 (n = 6), ST285 (n = 4) and ST1524 (n = 4)
were the most prevalent STs; 28 STs were repre-
sented by single isolates. Twelve ST clusters of
between two and 14 isolates were identified.
However, three of these STs were represented
by single isolates that displayed minor differences
when the entire porB gene sequences were com-
pared, and four of these STs comprised single
isolates that belonged to divergent serovars
(Figs 1 and 2).
Correlation between genotypic characteristics
and antimicrobial resistance
The level of intermediate susceptibility or resist-
ance to many antimicrobial agents is known to be
high in N. gonorrhoeae isolates from Arkhangelsk
[5]. In the present study, many of the STs were
represented by only occasional isolates; conse-
quently, it was not possible to determine definit-
ive correlations between any individual ST and
specific antimicrobial resistance profiles. How-
ever, among the STs represented by more than
three isolates, ST285 and ST1524 were non-ambi-
guously associated with multiresistance [5], i.e.,
intermediate susceptibility or resistance to
penicillins, tetracycline and ciprofloxacin or
kanamycin. Furthermore, some other STs, e.g.,
ST758, comprised isolates displaying multiresis-
tance (including one isolate with intermediate
susceptibility to ceftriaxone), but these STs also
comprised isolates susceptible to the same anti-
microbial agents, which may suggest local resist-
ance development de novo.
DISCUSSION
The present study provides unique and valuable
information regarding the population of N. gon-
orrhoeae strains transmitted during 2004 in the
Arkhangelsk region of Russia. The N. gonorrhoeae
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population was highly diverse and differed from
the N. gonorrhoeae populations disseminated in
some western European countries such as
Sweden, Scotland and England (http://www.
ng-mast.net). However, these data should be
interpreted with caution, as only limited numbers
of isolates were available from Arkhangelsk, and
the NG-MAST database may not be completely
representative.
All of the serovars characterised (n = 12) have
been identified previously in other countries.
However, the proportion of serogroup PorB1a
isolates (26%) was high in comparison with (e.g.)
Sweden, which reported 13% PorB1a isolates in
2005 [13]. This may also explain, in part, the
higher number of invasive and complicated cases
of gonorrhoea in Arkhangelsk (personal unpub-
lished data), as PorB1a strains are usually more
invasive than PorB1b strains [14]. Furthermore,
67% (20 ⁄ 30) and 60% (15 ⁄ 25), respectively, of the
NG-MAST porB and tbpB alleles identified, as well
as 83% (33 ⁄ 40) of the assigned STs, have not been
identified previously. In total, 61% (46 ⁄ 76) of the
isolates belonged to new STs. The seven remain-
ing STs have been detected previously in other
countries, e.g., Sweden, England, Scotland and
the USA (http://www.ng-mast.net). The 12 ST
clusters of isolates identified in the present study
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Fig. 1. Neighbour-joining phylogenetic tree describing the evolutionary relationships of entire porB gene sequences (993
unambiguously aligned nucleotides), encoding mature PorB, of Neisseria gonorrhoeae isolates (n = 76) cultured in
Arkhangelsk, Russia, during 2004. The most diverse porB1a sequence, i.e., from the isolate characterised as IA-1.2, ST1538,
was used to root the tree. The length of the branch dividing the PorB1a (WI) and PorB1b (WII ⁄ III) isolates has been reduced
by a factor of eight. The serovar and N. gonorrhoeae multi-antigen sequence typing (NG-MAST) sequence type (ST) of each
isolate is indicated. In cases of several isolates with an identical serovar and ST, these are indicated as (n = x); *denotes an
ST that has not been identified previously.
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indicate that many multiple transmission net-
works may exist in Arkhangelsk. The high num-
ber of unique STs (n = 28) may be a consequence
of sub-optimal diagnostic procedures, shortcom-
ings in partner tracing, import of strains by sexual
tourists from many different areas, foreign travel,
or the local emergence of new STs.
Comprehensive studies concerning gonor-
rhoea, particularly of N. gonorrhoeae populations
disseminated in Russia and other post-Soviet
countries, have not been published previously in
international scientific journals. Apart from the
use of sub-optimal diagnostic procedures and an
absence of phenotypic (antimicrobial susceptibil-
ity testing and serovar determination) and ⁄ or
genetic characterisation of N. gonorrhoeae isolates,
imperfect systems for case reporting and epide-
miological surveillance, as well as widespread
self-treatment with antimicrobial agents, are also
prevalent [2–5]. This is alarming, as local surveil-
lance data indicate that the prevalence of gonor-
rhoea is higher than estimated by EpiNorthData,
and that the prevalence is increasing in the
Arkhangelsk region [5]. Accordingly, it is crucial
in Arkhangelsk, as well as in many other areas of
Russia and other eastern European countries, to
optimise and assure the quality of the diagnostic
procedures for N. gonorrhoeae in accordance with
international recommendations [6–8], i.e., culture
more isolates, introduce a selective culture
medium and effective species confirmation
assays, standardise antimicrobial susceptibility
testing, and introduce a comprehensive quality
assurance control system [2–5].
Resistance to most of the traditional antimi-
crobial agents used for the treatment of gonor-
rhoea is widespread globally, and the level of
resistance is increasing in most countries world-
wide. However, there are marked geographical
variations in resistance, and effective therapy
should be informed by local surveillance.
Consequently, continuous national, regional and
local surveillance of the antimicrobial suscepti-
bility of N. gonorrhoeae and increasing antimicro-
bial consumption in eastern European countries
is essential. Published data concerning the
antimicrobial susceptibility of N. gonorrhoeae
strains in Russia are limited. However, the high
level of resistance in Arkhangelsk, and presum-
ably many other areas of Russia, means that
penicillins, ciprofloxacin, erythromycin, azithro-
mycin, kanamycin and tetracycline cannot be
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Fig. 2. Pie chart depicting the percen-
tages of differentNeisseria gonorrhoeae
multi-antigen sequence typing (NG-
MAST) sequence types (STs) identi-
fied among N. gonorrhoeae isolates
(n = 76) cultured in Arkhangelsk,
Russia, during 2004. The serovars
identified within each ST and among
the isolates displaying unique STs are
described in parentheses; *denotes an
ST that has not been identified previ-
ously. aAmong the unique STs,
89% (25 ⁄ 28) have not been identified
previously.
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recommended for treatment of gonorrhoea if the
results of antimicrobial susceptibility testing are
not available [5].
In the present study, porB gene sequencing
and NG-MAST showed a high level of congru-
ence, although NG-MAST was more discrimina-
tive overall. Occasional isolates belonging to
identical STs were further subdivided by full-
length porB gene sequencing [12,15]. As in
previous studies, genotypic characterisation was
more discriminatory than phenotypic character-
isation [9–12,15,16]. Serovar determination has
inherent shortcomings, e.g., subjective interpret-
ation of results, inconsistent reproducibility
(mainly inter-assay rather than intra-assay),
typeability, and a lack of congruence with
genetic typing [9,10,15,16]. Thus, although ser-
ovar determination is considered to be a rapid,
inexpensive and easily performed method for the
provision of primary epidemiological markers
and data concerning (e.g.) exposure of immuno-
logically important epitopes, the results obtained
need to be interpreted with caution. Ideally, a
genetic characterisation method, e.g., NG-MAST,
should be used. This is especially important in
geographical areas in which the N. gonorrhoeae
population is heterogeneous, in order to provide
precise and reliable data concerning the related-
ness of clinical isolates.
Precise methods for effective characterisation of
N. gonorrhoeae isolates can be crucial tools for
identification of more virulent or widely dissem-
inated strains in the community, for performance
of effective partner tracing, for discrimination or
confirmation of suspected clusters of cases of
gonorrhoea, or for recognition of core groups
containing (e.g.) high-frequency transmitters.
Consequently, data fundamental for the develop-
ment of improved control measures and inter-
ventions are provided.
In conclusion, the N. gonorrhoeae population
transmitted in Arkhangelsk was highly diverse
and differed from the N. gonorrhoeae populations
disseminated in some western European coun-
tries. The diagnosis of N. gonorrhoeae needs to be
optimised and the quality of the methodology
needs to be assured in Russia and many other
eastern European countries in accordance with
international recommendations. In addition, thor-
ough knowledge regarding the incidence of gon-
orrhoea, antibiotic susceptibility and other
phenotypic and genotypic characteristics of the
N. gonorrhoeae strains circulating in eastern Euro-
pean countries is crucial.
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